PACLITAXEL PROTEIN-BOUND PARTICLES J Code: J9258

Drug & Product Overview

HCPCS Descriptor Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg

HCPCS Added Date January 1, 2024

Manufacturer Teva

Route of Administration Intravenous

Generic Status HCPCS Discontinued

Dosage Type Single-Dose

Dosage Form Injection, Powder, Lyophilized, For Suspension

About PACLITAXEL PROTEIN-BOUND PARTICLES

Paclitaxel Protein-bound Particles is a medication aligned to the HCPCS J Code: J9258 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by Teva.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to J9258. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	PACLITAXEL PROTEIN-BOUND PARTICLES

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

PACLITAXEL PROTEIN-BOUND PARTICLES CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

PACLITAXEL PROTEIN-BOUND PARTICLES Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Adenocarcinoma of the Pancreas Metastatic Breast Cancer Non-Small Cell Lung Cancer

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Frequently Asked Questions

Is there an available Paclitaxel Protein-Bound Particles billing and coding guide?

We have not yet identified a manufacturer source of Paclitaxel Protein-Bound Particles billing and coding information.

Are there any available Paclitaxel Protein-Bound Particles patient assistance programs?

Our team did not identify a source for Paclitaxel Protein-Bound Particles patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Paclitaxel Protein-Bound Particles prescribing information?

PACLITAXEL PROTEIN-BOUND PARTICLES prescribing information can be found at the link below: Visit Here →

Where can I find Paclitaxel Protein-Bound Particles side effect information?

Our team has not yet identified a source of side effects information for PACLITAXEL PROTEIN-BOUND PARTICLES. Please check back in a few weeks.

Does billing PACLITAXEL PROTEIN-BOUND PARTICLES require JZ/JW wastage modifiers?

CMS does not include PACLITAXEL PROTEIN-BOUND PARTICLES (J9258) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9258. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.